BackCan-Fite Biopharma Overview

Can-Fite Biopharma Current Cash

Latest current cash for CANF: $5.5M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$5.53M
↑ 14.57% YoYΔ $703000.00 vs prior year quarter

Peer average

Loading

Can-Fite Biopharma Current Cash History

Loading

Can-Fite Biopharma vs. peers: Current Cash Comparison

Loading

Can-Fite Biopharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Can-Fite Biopharma (CANF) FAQ

Can-Fite Biopharma (CANF) currently reports a current cash of $5.5M as of December 2025. That compares with $4.8M in the prior-year period — up 14.6% year over year. Use the charts on this page to explore Can-Fite Biopharma's current cash history and peer comparisons.

Can-Fite Biopharma's current cash increased from $4.8M to $5.5M — a 14.6% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Can-Fite Biopharma reported $5.5M in current cash as of December 2025. That compares with $4.8M in the prior-year period — up 14.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $5.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Can-Fite Biopharma, and consider following CANF for alerts when major investors trade the stock.

Can-Fite Biopharma is classified in the Healthcare sector. On current cash, it currently shows $5.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CANF with unrelated industries.